Kirschenbaum A, Cheung P, Rajagopalan V, Yao S, Milgrim L, Kyprianou N
Am J Clin Exp Urol. 2024; 12(5):255-265.
PMID: 39584003
PMC: 11578768.
DOI: 10.62347/DZIU5992.
Wallon L, Khan I, Teng K, Koide A, Zuberi M, Li J
Proc Natl Acad Sci U S A. 2022; 119(43):e2204481119.
PMID: 36252024
PMC: 9618066.
DOI: 10.1073/pnas.2204481119.
Khan I, Koide A, Zuberi M, Ketavarapu G, Denbaum E, Teng K
Cell Rep. 2022; 38(6):110322.
PMID: 35139380
PMC: 8936000.
DOI: 10.1016/j.celrep.2022.110322.
Khan I, OBryan J
Methods Mol Biol. 2021; 2262:281-302.
PMID: 33977484
PMC: 8121162.
DOI: 10.1007/978-1-0716-1190-6_17.
Khan I, Marelia-Bennet C, Lefler J, Zuberi M, Denbaum E, Koide A
Small GTPases. 2021; 13(1):114-127.
PMID: 33949915
PMC: 9707541.
DOI: 10.1080/21541248.2021.1906621.
DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters.
Sutton M, Lu Z, Li Y, Zhou Y, Huang T, Reger A
Cell Rep. 2019; 29(11):3448-3459.e6.
PMID: 31825828
PMC: 6948147.
DOI: 10.1016/j.celrep.2019.11.045.
An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation.
Heard J, Phung I, Potes M, Tamanoi F
BMC Cancer. 2018; 18(1):69.
PMID: 29320991
PMC: 5763582.
DOI: 10.1186/s12885-017-3938-5.
A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.
Shin S, Lim D, Reddy K, Malakhova M, Liu F, Wang T
EBioMedicine. 2017; 25:22-31.
PMID: 29033371
PMC: 5704052.
DOI: 10.1016/j.ebiom.2017.09.029.
Analysis of K-Ras Interactions by Biotin Ligase Tagging.
Ritchie C, Mack A, Harper L, Alfadhli A, Stork P, Nan X
Cancer Genomics Proteomics. 2017; 14(4):225-239.
PMID: 28647697
PMC: 5572301.
DOI: 10.21873/cgp.20034.
AMP-activated protein kinase fortifies epithelial tight junctions during energetic stress via its effector GIV/Girdin.
Aznar N, Patel A, Rohena C, Dunkel Y, Joosen L, Taupin V
Elife. 2016; 5.
PMID: 27813479
PMC: 5119889.
DOI: 10.7554/eLife.20795.
Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy.
Gannon H, Kaplan N, Tsherniak A, Vazquez F, Weir B, Hahn W
Mol Cancer Res. 2015; 14(2):207-15.
PMID: 26582713
PMC: 4755909.
DOI: 10.1158/1541-7786.MCR-15-0321.
Identification of an oncogenic RAB protein.
Wheeler D, Zoncu R, Root D, Sabatini D, Sawyers C
Science. 2015; 350(6257):211-7.
PMID: 26338797
PMC: 4600465.
DOI: 10.1126/science.aaa4903.
Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling.
Aznar N, Midde K, Dunkel Y, Lopez-Sanchez I, Pavlova Y, Marivin A
Elife. 2015; 4:e07091.
PMID: 26126266
PMC: 4484057.
DOI: 10.7554/eLife.07091.
Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.
Russo A, Okur M, Bosland M, OBryan J
Cancer Lett. 2015; 359(2):262-8.
PMID: 25622909
PMC: 4351744.
DOI: 10.1016/j.canlet.2015.01.026.
Focus formation: a cell-based assay to determine the oncogenic potential of a gene.
Alvarez A, Barisone G, Diaz E
J Vis Exp. 2015; (94).
PMID: 25590282
PMC: 4354486.
DOI: 10.3791/51742.
Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.
Schmidt M, Donninger H, Clark G
J Biol Chem. 2014; 289(45):31102-10.
PMID: 25217643
PMC: 4223314.
DOI: 10.1074/jbc.M114.594283.
Induction of stem-like cells with malignant properties by chronic exposure of human lung epithelial cells to single-walled carbon nanotubes.
Luanpitpong S, Wang L, Castranova V, Rojanasakul Y
Part Fibre Toxicol. 2014; 11:22.
PMID: 24885671
PMC: 4040122.
DOI: 10.1186/1743-8977-11-22.
Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1.
Tanaka R, Seki Y, Saito Y, Kamiya S, Fujita M, Okutsu H
J Biol Chem. 2014; 289(25):17699-708.
PMID: 24808173
PMC: 4067204.
DOI: 10.1074/jbc.M113.546622.
Oncogenic RIT1 mutations in lung adenocarcinoma.
Berger A, Imielinski M, Duke F, Wala J, Kaplan N, Shi G
Oncogene. 2014; 33(35):4418-23.
PMID: 24469055
PMC: 4150988.
DOI: 10.1038/onc.2013.581.
GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells.
Populo H, Tavares S, Faustino A, Nunes J, Lopes J, Soares P
PeerJ. 2013; 1:e104.
PMID: 23904987
PMC: 3728761.
DOI: 10.7717/peerj.104.